Garland W A, Min B H, Birkett D J
Res Commun Chem Pathol Pharmacol. 1978 Dec;22(3):475-84.
Amitriptyline and its metabolite, nortriptyline, were measured in the plasma of eight humans for 96 hours following oral administration of a 75 mg dose of amitriptyline hydrochloride. Based on the 8 to 96 hour post dosing plasma concentration data, the terminal exponential half life of amitriptyline +/- S.D. was 22.4 +/- 4.3 hr. Based on the 24 to 96 hour concentration data, the "apparent" terminal half time of nortriptyline +/- S.D. was 26.0 +/- 7.4 hours for seven subjects. For these same seven subjects the relative area under the plasma concentration time curve of nortriptyline +/- S.D. was only 0.88 +/- 0.34 times that of amitriptyline. One subject whose apparent nortriptyline half time was 108 hours had a nortriptyline bioavailability 3.83 times that of amitriptyline. Average steady state plasma levels for 12 psychiatric patients who had received a 50 mg oral dose of amitriptyline three times a day for an average of 32 days could be predicted from the single dose plasma clearance of amitriptyline.
在8名受试者口服75毫克盐酸阿米替林后96小时内,测定其血浆中的阿米替林及其代谢产物去甲替林。根据给药后8至96小时的血浆浓度数据,阿米替林的终末指数半衰期±标准差为22.4±4.3小时。根据24至96小时的浓度数据,7名受试者去甲替林的“表观”终末半衰期±标准差为26.0±7.4小时。对于这7名受试者,去甲替林血浆浓度-时间曲线下的相对面积±标准差仅为阿米替林的0.88±0.34倍。1名受试者的去甲替林表观半衰期为108小时,其去甲替林生物利用度是阿米替林的3.83倍。根据阿米替林的单剂量血浆清除率,可以预测12名平均每天口服3次50毫克阿米替林、平均服药32天的精神科患者的平均稳态血浆水平。